Basaglar

Lilly, Boehringer’s Basaglar long-acting insulin now available in the U.S.
Mass Device
Thu, 12/15/16 - 06:41 pm
Eli Lilly
Boehringer Ingelheim
Basaglar
insulin
diabetes
long-acting insulin
Eli Lilly Launches Lantus Biosimilar To Boost Sales, But Not Without Risks
Seeking Alpha
Tue, 06/28/16 - 05:33 pm
Eli Lilly
Lantus
biosimilars
diabetes
Basaglar
Lilly gets its Lantus copycat Basaglar approved by FDA—but not as a biosimilar
BioPharma Dive
Thu, 12/17/15 - 02:00 pm
diabetes
Eli Lilly
Lantus
Basaglar
insulin
FDA
biosimilars
Sanofi
Eli Lilly insulin drug receives tentative U.S. approval
Yahoo/Reuters
Mon, 08/18/14 - 08:58 pm
Eli Lilly
insulin
FDA
diabetes
Basaglar
Boehringer Ingelheim